Literature DB >> 15358685

Combination therapy for pulmonary arterial hypertension: still more questions than answers.

M M Hoeper, A T Dinh-Xuan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358685     DOI: 10.1183/09031936.04.00072104

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  9 in total

Review 1.  [Pulmonary arterial hypertension in collagenoses: clinical features, epidemiology, pathogenesis, diagnosis and treatment].

Authors:  K Ahmadi-Simab; W L Gross
Journal:  Z Rheumatol       Date:  2006-07       Impact factor: 1.372

Review 2.  Drug treatment of pulmonary arterial hypertension: current and future agents.

Authors:  Marius M Hoeper
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Sildenafil in the treatment of pulmonary hypertension.

Authors:  Christopher F Barnett; Roberto F Machado
Journal:  Vasc Health Risk Manag       Date:  2006

4.  Survival with sildenafil and inhaled iloprost in a cohort with pulmonary hypertension: an observational study.

Authors:  Henning Gall; Natascha Sommer; Katrin Milger; Manuel J Richter; Robert Voswinckel; Dirk Bandorski; Werner Seeger; Friedrich Grimminger; Hossein-Ardeschir Ghofrani
Journal:  BMC Pulm Med       Date:  2016-01-12       Impact factor: 3.317

5.  Pulmonary Hypertension: Scientometric Analysis and Density-Equalizing Mapping.

Authors:  Michael Götting; Mario Schwarzer; Alexander Gerber; Doris Klingelhöfer; David A Groneberg
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

6.  The effects of sitaxentan on sildenafil pharmacokinetics and pharmacodynamics in healthy subjects.

Authors:  Fiona Stavros; William G Kramer; Martin R Wilkins
Journal:  Br J Clin Pharmacol       Date:  2010-01       Impact factor: 4.335

7.  Mutual pharmacokinetic interactions between steady-state bosentan and sildenafil.

Authors:  Gary Burgess; Hans Hoogkamer; Lorraine Collings; Jasper Dingemanse
Journal:  Eur J Clin Pharmacol       Date:  2007-11-27       Impact factor: 3.064

Review 8.  Review of bosentan in the management of pulmonary arterial hypertension.

Authors:  Eli Gabbay; John Fraser; Keith McNeil
Journal:  Vasc Health Risk Manag       Date:  2007

9.  Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Medical and surgical management for pulmonary arterial hypertension.

Authors:  Majdy M Idrees; John Swiston; Imran Nizami; Abdullah Al Dalaan; Robert D Levy
Journal:  Ann Thorac Med       Date:  2014-07       Impact factor: 2.219

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.